Skip to main content
MedPathMedPath Home
Clinical Trials/EUCTR2006-004016-40-IT
EUCTR2006-004016-40-IT
Active, not recruiting
Not Applicable

APPLICATION OF PHARMACOGENOMICS IN THE TREATMENT OF ELDERLY PATIENTS WITH ADVANCED COLORECTAL CANCER - PHARMACOGENOMICS IN THE ELDERLY

AZIENDA OSPEDALIERO UNIVERSITARIA OSPEDALI RIUNITI UMBERTO I - G.M.LANCISI - G.SALESI0 sitesJuly 3, 2007
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsELDERLY PATIENTS WITH METASTATIC COLORECTAL CANCERMedDRA version: 6.1Level: HLTClassification code 10010040

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
ELDERLY PATIENTS WITH METASTATIC COLORECTAL CANCER
Sponsor
AZIENDA OSPEDALIERO UNIVERSITARIA OSPEDALI RIUNITI UMBERTO I - G.M.LANCISI - G.SALESI
Status
Active, not recruiting
Last Updated
14 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 3, 2007
End Date
TBD
Last Updated
14 years ago
Study Type
Interventional clinical trial of medicinal product
Sex
All

Investigators

Sponsor
AZIENDA OSPEDALIERO UNIVERSITARIA OSPEDALI RIUNITI UMBERTO I - G.M.LANCISI - G.SALESI

Eligibility Criteria

Inclusion Criteria

  • •CYTOLOGICALLY OR HISTOLOGICALLY DIAGNOSED METASTATIC COLORECTAL CANCER BIDEMENSIONALLY EVALUABLE DISEASE METASTATIC DISEASE ECOG LESS OR EQUAL TO 2 AGE 70 OR OLDER NO PREVIOUS CHEMOTHERAPY TREATMENT FOR METASTATIC DISEASE WRITTEN INFORMED CONSENT GOOD HEMATOLOGICAL, LIVER AND RENAL FUNCTIONS
  • •Are the trial subjects under 18? no
  • •Number of subjects for this age range:
  • •F.1\.2 Adults (18\-64 years) no
  • •F.1\.2\.1 Number of subjects for this age range
  • •F.1\.3 Elderly (\>\=65 years) yes
  • •F.1\.3\.1 Number of subjects for this age range

Exclusion Criteria

  • •PREVIOUS DIAGNOSIS OF TUMOUR OTHER THAN BASAL SKIN CARCINOMA OR IN SITU CANCER OF THE UTERINE CERVIX METAL ILLNESS SYMPTOMATIC CNS METASTASES INFLAMMATORY BOWEL DISEASE SERIOUS ORGAN FAILURE

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Clinical utility of genetic testing based treatment of depression in India as per recommendations of international guidelines
CTRI/2022/08/044982Indian Council of Medical Research
Completed
Not Applicable
Clinical pharmacology and pharmacogenetic study on the clinical response for tamoxifeBreast cancer
JPRN-UMIN000001411Saitama Medical University, Saitama International Medical Center100
Recruiting
Not Applicable
Pharmacogenetic analysis to investigate the association between efficacy and neurotoxicity of oxaliplatin and single nucleotide polymorphismsColorectal cancer
JPRN-UMIN000002490Kyoto University Hospital133
Active, not recruiting
Not Applicable
Pharmacogenomics in optimizing the chemotherapy in the treatment of colorectal carcinoma - AOBS-FOBERL-COBIOMARCOLORECTAL NEOPLASTIC DISEASEMedDRA version: 9.1Level: LLTClassification code 10009973MedDRA version: 9.1Level: LLTClassification code 10009974
EUCTR2010-019805-41-ITAZIENDA OSPEDALIERA SPEDALI CIVILI DI BRESCIA
Active, not recruiting
Not Applicable
A retrospective pharmacogenetic analysis of patients with elevated liver enzymes (Hy s law cases or AST/ALT > 10x ULN) in clinical studies CCOX189A0117, CCOX189A2332, CCOX189A2369, CCOX189A0126, CCOX189A0112, CCOX189A0109 or CCOX189A2361 - NDpatients with elevated liver enzymes (Hy s law cases or AST/ALT > 10x
EUCTR2009-017148-15-ITOVARTIS FARMA37